Scientists at the Australian Garvan Institute of Medical Research have finally reached a conclusion to the failure of insulin production in type 2 diabetes. Considered a breakthrough in diabetes research, they were successful in isolating the PKCepsilon (PKCe), an enzyme which present during diabetes aria slows down the production of insulin in type 2 diabetics.

Lead authors of the study, Associate Prof. Trevor Biden and Dr. Carsten Schmitz-Peiffer, note that the findings in this study could lead to the development of a medication that restrains the PKCe and allow insulin production in the pancreas. Biden notes that there are a lot of current medications that prompts the body to create insulin, but none has actually developed a drug that addresses the need to stop the PKCe from hindering the pancreas to produce insulin.

Dr.Schmitz-Peiffer is positive about the outcome of further studies on PKCe, saying that it could lead to the safeguarding of individuals who are at high risk in developing type 2 diabetes. “Blocking PKCe won’t stop them from becoming insulin-resistant, but it will restore their capacity to compensate,” he says.

Related terms:

• solved cases of pregnancy with diabetes type 2
• dr michael lim-villa
• insulin deficiency in type 2 diabetes
• anxiety PKC e 2012
• coffee good for the insulin deficiency
• diabetes research enzyme pkce
• diabetes type 2 breakthrough 2012 insulin resistance
• insulin breakthroughs 2011 type2
• insulin deficiency
• PKCe glucagon
• PKCe obesity and insulin production
• research studies on coffee as treatment to prevent diabetes - philippines
• type 2 diabetes with insulin deficiency
• what is insulin deficiency in type 2 diabetes

Related Posts:

• No Related Posts